Resources
This section features expert content on medical device regulations, RegTech approaches, and R&D strategies.
11.03.2026 - Most medical device manufacturers in Turkey still use Excel for risk management.
But is this approach sustainable in the age of the MDR?
In my article, I analyzed the following question:
Why is RegTech no longer just a quality tool but is becoming a strategic infrastructure in the medical sector?
https://www.linkedin.com/feed/update/urn:li:activity:7437457341958176768
17.03.2026 - A medical device manufacturer in Turkey holds ISO 13485 certification.
However, in the post-MDR environment, the following question is becoming increasingly critical:
"Does being certified truly mean sustainable compliance?"
Observations in the field indicate the following:
The issue is not a lack of knowledge about regulations, but an inability to sustainably manage the
requirements-risk-testing-change-PMS chain
In this new article, the RegTech maturity level of manufacturers in Turkey and the regulatory tipping point
post-TRL are analyzed.
The article covers the following topics:
- Why is TRL 6 the regulatory threshold,
- Why is the regulatory burden surging post-MDR?
- Why is ISO 13485 Clause 4.1.6 critical?
- How does the RegTech architecture work
https://www.linkedin.com/feed/update/urn:li:activity:7439591048588296192
25.03.2026 - Is the technical file still just a folder? Or is it a system?
👉 How does the technical file transform into a closed-loop regulatory system?
(Field data → Risk → Design → Testing → back to market)
📊 And the most critical prediction:
👉 The technical file is no longer an "output"
👉 A "core system" that manages the product lifecycle
🎯 If you're still:
• Using Excel + Word + folders
• The Requirement–Risk–Test link is broken
• PMS data isn't feeding back into the technical file
➡️ This isn't just an operational problem; A strategic regulatory risk
https://www.linkedin.com/feed/update/urn:li:activity:7442453968624132097

